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Objective. Our team created a knowledge, attitudes, and practice (KAP) survey in order to assess changes over time in healthcare
provider and community member awareness of Zika virus symptoms, transmission, treatment, and current and future concerns.
Study Design. The cross-sectional survey was issued at an academic medical center in Washington, DC, and via an online link to
healthcare providers and community members between June and August 2016. Survey distribution was then repeated the following
year, fromMarch to April 2017. Outcomes were compared by survey year and healthcare provider versus communitymember status
using SAS ProgramVersion 9.4. Results. Significant differences in knowledge, attitudes, and practices existed between 2016 and 2017
survey time points. By 2017, more respondents had knowledge of various Zika virus infection characteristics; however healthcare
provider knowledge also waned in certain areas. Attitudes towards Zika virus infection displayed an overall decreased concern
by 2017. Practice trends by 2017 demonstrated fewer travel restrictions to Zika-endemic areas and increased mosquito protective
measures within the US. Conclusions. Our results provide novel insight into the transformation of knowledge, attitudes, and
practice of community members and healthcare providers regarding Zika virus since its declaration as a public health emergency
of international concern in 2016.
1. Introduction
Zika virus infection was declared a public health emergency
in 2016. Zika virus infections have been present in Africa
and Asia since the 1940s and have since spread dramatically
to mainly in the Americas and western Pacific [1]. Zika
virus was first identified in a rhesus monkey in Uganda in
1947, during which time the virus vector was discovered
as the Aedes africanus mosquito [2–4]. Since the initial
detection of Zika virus, epidemiologists have mapped its
global migration through the remainder of the 20th century
[5]. In October of 2015, Brazil reported “an unusual increase”
in the number of cases of microcephaly among newborns.
After increased investigative efforts, Brazil reported detection
of Zika virus in amniotic fluid samples frompregnant women
with ultrasound-confirmedmicrocephaly, culminating in the
issuance of a national public health emergency [6]. Zika virus
reached the United States (US) in mid-2016 when the first
local-transmission was documented in Miami on July 29,
2016 [7]. As of July 2017, there had been over 143 symptomatic
Zika virus disease cases reported within the US and over 513
cases within US Territories [8].
Since the first documented cases in the western hemi-
sphere, the scientific community has made substantial
progress in terms of understanding Zika virus transmission
and outcomes. It is known that an infected mother can pass
the Zika virus vertically to her fetus during pregnancy as
well as during the delivery of her infant [9]. The Zika virus
can also be passed through sexual intercourse, even if the
infected person is asymptomatic [9]. There are reports of
Zika virus infections acquired through laboratory exposure
[9]. Othermodes of transmission are being investigated, such
as blood transfusion and healthcare occupational exposure.
The most common symptoms of a Zika infection include
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fever, rash, headache, joint pain, conjunctivitis, and muscle
pain. Zika virus has been associated with specific patterns
of neurologic and anatomic abnormalities in newborns,
including microcephaly (congenital small head size leading
to brain abnormalities), decreased brain tissue volume, and
ocular damage [9]. Zika infection is diagnosed by screening
of symptoms and recent travel history followed by testing
of blood or urine. While there is no commercially available
vaccine or targeted treatment for Zika virus, symptoms are
treated by rest, hydration, and fever-reducingmedication [9].
Despite substantial progress in understanding Zika virus
pathophysiology among the scientific community, to our
knowledge there is no study or data regarding the evolution
in knowledge, awareness, and practice among community
members and healthcare providers with regard to Zika virus
during this time period. Given this void, the aim of our
studywas to analyze the change in knowledge, awareness, and
prevention/practice regarding Zika infection during a critical
time in the development of understanding of the virus.
2. Study Design
A Zika questionnaire was composed by a multidisciplinary
team of experts consisting of maternal-fetal-medicine physi-
cians, public health specialists, general medicine providers,
and obstetrician-gynecologist generalist physicians. This
cross-sectional survey was distributed in two platforms.
First, patients and other community members visiting the
outpatient obstetrics and gynecology clinics at a mid-size
academic center in Washington, DC, were approached by
medical student study volunteers to take the survey prior
to their scheduled appointments over a 6-week period from
late June to early August 2016. This time period was chosen
because, during this interval, information about Zika virus
and practices to safely prevent transmission were at the
forefront of media attention due to many uncertainties
surrounding the virus, and it is a common time for our
study participants to be traveling to areas prevalent with Zika
virus.The survey was loaded onto handheld tablet computers
via the secure REDCap platform and volunteers approached
respondents at random during normal clinic hours; the
intervals of office survey administration were dependent
on the availability of volunteers. Second, the survey was
emailed to community members and healthcare providers
using REDCap to collect the data. The REDCap survey
link was emailed to various listservs within the academic
medical community, including OB/GYN resident and faculty
listservs, medical student listservs, and the Rodham Institute.
The survey was also emailed to nonmedical personnel via
social media networks in order to obtain a random sampling
of community members. The survey distribution was then
repeated in the same fashion over 6 weeks nearly one year
later, from early March to late April 2017. This time period
was chosen because the authors felt that sufficient time had
passed since the first survey administration to gauge a change
in knowledge, attitudes, and practices; Zika virus garnered
much less media attention around this time due to increased
availability of information regarding the virus.
Healthcare providers were defined as anyone involved in
themedical field and were stratified as either a physician (pri-
mary care, OB/GYN, or other specialty physicians), or non-
physician, which could include butwas not limited tomedical
students, NPs, PAs, genetic counselors, and other types
of providers. Information about the type of nonphysician
healthcare providerswas not collected. Communitymembers
were defined as anyone receiving care at the clinic where the
survey was administered or anyone whose occupation was
not in the healthcare field. The survey sample size included
174 respondents (63% community members; 37% healthcare
providers) during the first round and 277 respondents (65%
community members; 35% healthcare providers) during the
second round. No face-to-face interviews were conducted. At
the end of the survey the respondent was provided with a link
to the most current CDC Guidelines on Zika virus.
Data was stored in the George Washington University
REDCap database. Outcomes were compared by year of
survey administration and healthcare provider versus com-
munity member status. Data analysis was performed using
SAS Program Version 9.4. The median and interquartile
range was computed for continuous variables. Frequencies
were computed for categorical variables. Chi-square tests
were used to compare frequencies of categorical variables
across groups. 𝑝 values < 0.05 were considered statistically
significant.
The study was approved by the Office of Human
Research-Institutional ReviewBoard atTheGeorgeWashing-
ton University (Protocol #031653, approved April 20, 2016).
Respondent identity was anonymous to protect confidential-
ity.
3. Results
Of the approximately 800 individuals approached to take
the survey either in the clinic or via email link in each
round, approximately half were healthcare providers and half
were community members, and 451 potential participants
responded. Approximately 75 of these were community
members approached in the waiting roomof the clinic. Of the
451 total survey respondents, there were more respondents
in the second round of surveys (277) compared to the first
(174). Fifty-seven respondents (33%) in the first round of
surveys were healthcare providers and 60% of these were
physicians, whereas 89 (32%) were healthcare providers in
the second round but only 37% of these were physicians. The
population surveyed was majority Caucasian females with
private medical insurance (Table 1).
Significant differences in knowledge existed between 2016
and 2017 survey time points (Table 2). More community
members were aware of Zika virus in the second round of
surveys (99% in 2017 versus 94% in 2016, 𝑝 = 0.02). More
respondents were able to correctly identify Zika infection
symptoms in 2017, and this remained true for both com-
munity members (64% versus 46%, 𝑝 = 0.019) as well as
healthcare providers (79% versus 74%, 𝑝 = 0.19). When
asked if anyone had been infected with Zika virus within
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Table 1: Demographic characteristics of survey respondents.
Characteristic Details 2016 Survey Frequency (%) 2017 Survey Frequency (%)
Gender
Male 28/174 (16) 40/277 (14)
Female 129/174 (74) 215/277 (78)
No answer 17/174 (10) 22/277 (8)
Marital status
Single 52/174 (30) 125/277 (45)
Partnered 18/174 (10) 33/277 (12)
Married 79/174 (45) 89/277 (32)
Other 25/174 (15) 30/277 (11)
Highest level of education
High School 12/174 (7) 0/277 (0)
College 32/174 (18) 84/277 (30)
Graduate school 60/174 (34) 112/277 (40)
Post-Grad 53/174 (30) 60/277 (22)
No answer 17/174 (10) 21/277 (8)
Average income
<$25,000 36/174 (21) 90/277 (32)
$25,000–50,000 12/174 (7) 30/277 (11)
$50,000–75,000 31/174 (18) 44/277 (16)
$75,000–100,000 17/174 (10) 24/277 (9)
>$100,000 39/174 (22) 39/277 (14)
Prefer not to answer 17/174 (10) 29/277 (10)
No answer 22/174 (13) 21/277 (8)
Ethnicity
Caucasian 92/174 (53) 188/277 (68)
African American 27/174 (15) 14/277 (5)
Hispanic 11/174 (6) 11/277 (4)
Asian 18/174 (10) 31/277 (11)
Other 9/174 (5) 12/277 (4)
No answer 17/174 (10) 21/277 (8)
County of birth
US 136/174 (78) 219/277 (79)
Other 21/174 (12) 36/277 (13)
No answer 17/174 (10) 22/277 (8)
Country of residency
US 156/174 (90) 252/277 (91)
Other 0/174 (0) 2/277 (1)
No answer 18/174 (10) 23/277 (8)
State of residence
Washington, DC 67/174 (39) 73/277 (26)
Maryland 30/174 (17) 32/277 (12)
Virginia 29/174 (17) 52/277 (19)
Other state 10/174 (6) 60/277 (22)
No answer 38/174 (22) 60/277 (22)
Type of insurance
Medicare 8/174 (5) 2/277 (1)
Medicaid 11/174 (6) 4/277 (1)
Private 134/174 (77) 244/277 (88)
None 1/174 (1) 4/277 (1)
No answer 20/174 (11) 23/277 (8)
Healthcare provider status
Primary Care physician 10/174 (6) 8/277 (3)
OB/GYN physician 16/174 (9) 15/277 (5)
Other physician 8/174 (5) 10/277 (4)
Non-physician provider 23/174 (13) 56/277 (20)
Non-provider 117/174 (67) 188/277 (68)
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Table 1: Continued.
Characteristic Details 2016 Survey Frequency (%) 2017 Survey Frequency (%)
Pregnancy status
Not pregnant 93/174 (53) 205/277 (74)
Pregnant 32/174 (18) 10/277 (4)
Planning to be pregnant 8/174 (5) 9/277 (3)
Postpartum (<6wk) 3/174 (2) 1/277 (0)
Not applicable 21/174 (12) 31/277 (11)
No answer 17/174 (10) 21/277 (8)
Primary source of healthcare information
Health publication 30/174 (17) 37/277 (13)
Internet 55/174 (32) 100/277 (36)
Social Media 2/174 (1) 4/277 (1)
Healthcare provider 36/174 (21) 56/277 (20)
Newspaper 6/174 (3) 12/277 (4)
At work 7/174 (4) 21/277 (8)
Other 20/174 (11) 26/277 (9)
No answer 18/174 (10) 21/277 (8)
Where would you like to obtain your
healthcare information
Text Message 7/174 (4) 8/277 (3)
Health publication 31/174 (18) 43/277 (16)
Internet 45/174 (26) 90/277 (32)
Social Media 4/174 (2) 15/277 (5)
Healthcare provider 43/174 (25) 61/277 (22)
Newspaper 8/174 (5) 9/277 (3)
Other 19/174 (11) 30/277 (11)
No answer 17/174 (10) 21/277 (8)
the US at the time of survey collection, more community
members were aware in 2017 compared to 2016 (91% versus
65%, p ≤ 0.0001), and a similar trend was noted for healthcare
providers (84% versus 61%, 𝑝 = 0.002). Knowledge with
regard to a link between Zika infection during pregnancy
and microcephaly increased among community respondents
(95% in 2017 versus 90% in 2016, 𝑝 = 0.09), and this
knowledge remained basically unchanged among healthcare
providers (100% versus 98%, 𝑝 = 0.25). Knowledge about
safety of mosquito-bite prevention strategies such as DEET
and permethrin during pregnancy actually decreased over
time, including for both healthcare providers and community
members with a lower proportion of responses indicating
knowledge of DEET and permethrin safety in pregnancy in
2017. However, a substantial number of respondents answered
“I do not know” to this question in both years. Knowledge
regarding effective protective measures against mosquitos
changed among communitymembers over time: in 2017, 93%
(versus 82% in 2016) would remove standing water (𝑝 =
0.015), 96% (versus 78%) would sleep under a mosquito
net (p ≤ 0.0001), and 96% (versus 85%) would use screens
on windows and doors (𝑝 = 0.0049); healthcare provider
knowledge essentially remained the same between the survey
time points.
Community member knowledge appears to increase for
certain topics while healthcare provider knowledge waned
between the two time periods. Knowledge of Zika infection
symptomatic treatment improved for the community respon-
dents with 36% in 2017 being aware that Tylenol and rest
was the primary modality of treatment compared to 22% in
2016 (𝑝 = 0.009). However, this value trended differently
for healthcare providers: 72% in 2016 had knowledge about
treatment options compared to 56% in 2017 (𝑝 = 0.18).
More community members were able to correctly answer
that a Zika vaccine was not commercially available when
comparing 2017 to 2016 (87% versus 76%, 𝑝 = 0.048);
however the opposite trend was seen among healthcare
providers (84% in 2017 versus 98% in 2016, 𝑝 = 0.048).
When questioned about the common breeding site of the
Aedes mosquito, 93% of community members were able to
correctly identify that the mosquito breeds near standing
water compared to 80% in 2016 (𝑝 = 0.007); there was a
small trend in the opposite direction for healthcare provider
respondents (90% in 2017 versus 96% in 2016, 𝑝 = 0.38).
Attitudes towards Zika infection changed over time
(Table 3). The overall concern among community members
for Zika infection being a serious problem in the respondents’
home area decreased in 2017 survey administration (69%
in 2017 versus 87% in 2016, 𝑝 ≤ 0.0001). This trend was
similar for healthcare providers (80% versus 84%, 𝑝 = 0.18).
When asked if Zika virus prevalence makes them worried for
their families, less community members (29% versus 35%,
𝑝 = 0.02) and healthcare providers (24% versus 30%, 𝑝 =
0.18) were concerned in 2017. Additionally, more community
members believed that a vaccine against Zika virus infection
Infectious Diseases in Obstetrics and Gynecology 5
Table 2: Responses to “knowledge” questions regarding Zika virus disease and infection.
Community Member Responses Healthcare Provider Responses
2016 Survey (%) 2017 Survey (%) 95% CI 2016 Survey (%) 2017 Survey (%) 95% CI
Are you aware of Zika virus?
Yes 91/97 (94) 165/166 (99) 0.02 57/57 (100) 87/89 (98) 0.25
No 2/97 (2) 0/166 (0) 0/57 (0) 2/89 (2)
No answer 4/97 (4) 1/166 (1) 0/57 (0) 0/89 (0)
How is the Zika virus spread?
Fly bite 0/97 (0) 1/166 (1) 0/57 (0) 0/89 (0)
Mosquito Bite 92/97 (95) 163/166 (98) 0.19 56/57 (98) 87/89 (98) 0.24
Do not know 1/97 (1) 1/166 (1) 1/57 (2) 0/89 (0)
No answer 4/97 (4) 1/166 (1) 0/57 (0) 2/89 (2)
Which of the following is NOT a common
symptom of Zika virus infection?
Fever 2/97 (2) 1/166 (1) 0/57 (0) 2/89 (2)
Rash 3/97 (3) 5/166 (3) 4/57 (7) 2/89 (2)
Pneumonia 45/97 (46) 107/166 (64) 0.019 42/57 (74) 70/89 (79) 0.19
Joint Pain 2/97 (2) 2/166 (1) 1/57 (2) 0/89 (0)
Conjunctivitis (red eyes) 15/97 (15) 28/166 (17) 5/57 (9) 3/89 (3)
Do not know 26/97 (27) 22/166 (13) 5/57 (9) 12/89 (13)
No answer 4/97 (4) 1/166 (1) 0/57 (0) 2/89 (2)
What percentage of people infected with
Zika virus will have symptoms?
20% 38/97 (39) 76/166 (46) 29/57 (51) 47/89 (53)
40% 16/97 (16) 28/166 (17) 0.24 11/57 (19) 11/89 (12) 0.52
60% 3/97 (3) 7/166 (4) 2/57 (4) 1/89 (1)
80% 1/97 (1) 1/166 (1) 0/57 (0) 1/89 (1)
Do not know 34/97 (35) 53/166 (32) 15/57 (26) 27/89 (30)
No answer 5/97 (5) 1/166 (1) 0/57 (0) 2/89 (2)
What is the treatment for Zika virus
infection?
Antibiotics 5/97 (5) 10/166 (6) 0/57 (0) 2/89 (2)
Antivirals 26/97 (27) 53/166 (32) 0/57 (0) 3/89 (3)
Antifungals 0/97 (0) 0/166 (0) 7/57 (12) 19/89 (21)
Tylenol and rest 21/97 (22) 59/166 (36) 0.009 41/57 (72) 50/89 (56) 0.18
Do not know 41/97 (42) 43/166 (26) 9/57 (16) 15/89 (17)
No answer 4/97 (4) 1/166 (1) 0/57 (0) 2/89 (2)
Has anyone been infected with Zika virus
in the US?
Yes 63/97 (65) 151/166 (91) 0.0001 35/57 (61) 75/89 (84) 0.002
No 20/97 (21) 7/166 (4) 18/57 (32) 7/89 (8)
Do not know 9/97 (9) 7/166 (4) 4/57 (7) 5/89 (5)
No answer 5/97 (5) 1/166 (1) 0/57 (0) 2/89 (2)
Has anyone been infected with Zika virus
by traveling from the US to known Zika
areas outside the US?
Yes 84/97 (87) 151/166 (91) 0.24 53/57 (93) 83/89 (93) 0.64
No 4/97 (4) 6/166 (3) 1/57 (2) 1/89 (1)
Do not know 5/97 (5) 8/166 (5) 3/57 (5) 3/89 (3)
No answer 4/97 (4) 1/166 (1) 0/57 (0) 2/89 (2)
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Table 2: Continued.
Community Member Responses Healthcare Provider Responses
2016 Survey (%) 2017 Survey (%) 95% CI 2016 Survey (%) 2017 Survey (%) 95% CI
Is there an approved vaccine for Zika
virus?
Yes 2/97 (2) 6/166 (4) 1/57 (2) 4/89 (4)
No 74/97 (76) 144/166 (87) 0.048 56/57 (98) 75/89 (84) 0.048
Do not know 17/97 (17) 14/166 (8) 0/57 (0) 8/89 (9)
No answer 4/97 (4) 2/166 (1) 0/57 (0) 2/89 (2)
Is there a link between Zika virus and the
birth defect microcephaly (small head)?
Yes 87/97 (90) 157/166 (95) 0.09 57/57 (100) 87/89 (98) 0.25
No 0/97 (0) 1/166 (1) 0/57 (0) 0/89 (2)
Do not know 5/97 (5) 7/166 (4) 0/57 (0) 0/89 (0)
No answer 5/97 (5) 1/166 (1) 0/57 (0) 2/89 (2)
Can an infected man transfer Zika virus to
a woman through sexual activity?
Yes 74/97 (76) 144/166 (87) 0.12 52/57 (91) 74/89 (83) 0.4
No 1/97 (1) 4/166 (2) 3/57 (5) 6/89 (7)
Do not know 14/97 (14) 13/166 (8) 1/57 (2) 3/89 (3)
It is unknown 3/97 (3) 2/166 (1) 1/57 (2) 1/89 (1)
No answer 5/97 (5) 3/166 (2) 0/57 (0) 5/89 (5)
Can an infected mother transfer Zika virus
to her unborn baby?
Yes 67/97 (69) 144/166 (87) 0.008 52/57 (91) 75/89 (84) 0.34
No 3/97 (3) 2/166 (1) 1/57 (2) 1/89 (1)
Do not know 19/97 (19) 12/166 (7) 3/57 (5) 4/89 (5)
It is unknown 3/97 (3) 5/166 (3) 1/57 (1) 3/89 (3)
No answer 5/97 (5) 3/166 (2) 0/57 (0) 6/89 (6)
What is the common breeding site for the
mosquito that spreads Zika virus?
standing water 78/97 (80) 155/166 (93) 0.007 55/57 (96) 80/89 (90) 0.38
running water 0/97 (0) 1/166 (1) 0/57 (0) 1/89 (1)
salt water 0/97 (0) 1/166 (1) 0/57 (0) 0/89 (0)
Do not know 13/97 (13) 6/166 (3) 2/57 (4) 5/89 (6)
No answer 6/97 (6) 3/166 (2) 0/57 (0) 3/89 (3)
Is DEET safe in pregnancy?
Yes 24/97 (25) 34/166 (20) 0.19 28/57 (49) 30/89 (34) 0.05
No 29/97 (30) 60/166 (36) 19/57 (33) 26/89 (29)
Do not know 38/97 (39) 69/166 (42) 10/57 (18) 29/89 (33)
No answer 6/97 (6) 3/166 (2) 0/57 (0) 4/89 (4)
Is permethrin safe in pregnancy?
Yes 10/97 (10) 19/166 (11) 0.18 19/57 (33) 19/89 (21) 0.17
No 10/97 (10) 20/166 (12) 9/57 (16) 19/89 (21)
Do not know 69/97 (71) 123/166 (74) 29/57 (51) 47/89 (53)
No answer 8/97 (8) 4/166 (2) 0/57 (0) 4/89 (4)
Where should you apply insect repellent?
Under sunscreen 11/97 (11) 24/166 (14) 7/57 (12) 16/89 (18)
Over sunscreen 43/97 (44) 87/166 (52) 0.05 38/57 (67) 38/89 (43) 0.04
Do not know 35/97 (36) 52/166 (31) 11/57 (19) 32/89 (36)
No answer 8/97 (8) 3/166 (2) 1/57 (1) 3/89 (3)
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Table 2: Continued.
Community Member Responses Healthcare Provider Responses
2016 Survey (%) 2017 Survey (%) 95% CI 2016 Survey (%) 2017 Survey (%) 95% CI
If infected with Zika virus, when is one
most likely to infect others?
First week of symptoms 20/97 (21) 51/166 (31) 0.09 26/57 (46) 29/89 (33) 0.24
Second week of symptoms 8/97 (8) 13/166 (8) 4/57 (7) 6/89 (6)
Third week of symptoms 2/97 (2) 6/166 (4) 2/57 (4) 1/89 (1)
Do not know 60/97 (62) 93/166 (56) 25/57 (44) 50/89 (56)
No answer 7/97 (7) 3/166 (2) 1/57 (0) 3/89 (3)
These precautions will help to reduce the
risk of mosquito bites (yes/no)
Remove standing water 80/97 (82) 154/166 (93) 0.015 56/57 (98) 81/89 (91) 0.29
Sleep under a mosquito net 76/97 (78) 160/166 (96) 0.0001 54/57 (95) 83/89 (93) 0.15
Use screens on windows and doors 82/97 (85) 160/166 (96) 0.0049 56/57 (98) 84/89 (94) 0.19
was important when comparing 2017 to 2016 (89% versus
80%,𝑝 = 0.095); notably, this trendwas not witnessed among
healthcare providers (87% versus 89%,𝑝 = 0.03).With regard
to screening all pregnant patients for Zika exposure or infec-
tion, 61% of community members in both rounds of surveys
believed that this should be a routine prenatal policy (𝑝 =
0.0083). Notably, more healthcare providers believed that all
pregnant mothers should be screened when comparing 2017
to 2016 (53% versus 46%, 𝑝 = 0.085). Overall concern among
community members for Zika virus transmission through
sexual activity remained unchanged; however a decline in
concern was noted among healthcare providers (70% in
2017 versus 82% 2016, 𝑝 = 0.089). Approximately 36% of
community members were not concerned about having a
child withmicrocephaly secondary to a Zika infection, which
was an improvement from 2016 (26%, 𝑝 = 0.01); a similar
trendwas noted for healthcare provider respondents over this
time period (33% in 2017 versus 46% in 2016,𝑝 = 0.02).When
asked about having a child with learning disabilities due to a
Zika infection, less community members (26% in 2017 versus
37% in 2016, 𝑝 = 0.009) and healthcare providers (34% in
2017 versus 40% in 2016, 𝑝 = 0.04) were concerned by the
second round of survey distribution.
Practices related to Zika changed over time as well
(Table 4).The overall trend in the second cohort compared to
the first was that less communitymembers planned to restrict
travel to Zika-endemic areas (37% versus 49%, 𝑝 = 0.048).
A similar trend was noted among healthcare professionals,
although not statistically significant (35% in 2017 versus
47% in 2016, 𝑝 = 0.19). When asked if respondents
would take protective measures against mosquito infections
if traveling to a Zika-endemic area, there was no statistically
significant change in planned practice from 2016 to 2017
for both community members and healthcare providers.
Furthermore, the overall trend was noted by 2017 that both
healthcare providers and community members alike would
plan for greatermosquito preventivemeasures within the US,
including greater use of insect repellent and sleeping under
a mosquito net; there was no change in anticipated practice
of using screens on windows or doors. When community
members were asked if they were to go to an area where
Zika virus is spread and were pregnant, less would refrain
from intercourse during the pregnancy (5% in 2017 versus
10% in 2016, 𝑝 = 0.13); a similar trend was seen if their
partners traveled to a Zika-endemic area (8% versus 14%,
𝑝 = 0.13). When healthcare providers responded to these
same questions, there was no identifiable trend or statistically
significant association. Although statistically insignificant,
less community members plan to use condoms during the
entire pregnancy if theywere to go to an areawhere Zika virus
is spread and are pregnant (11% in 2017 versus 4% in 2016,
𝑝 = 0.26); a similar trend was noted if their partners went to
a Zika-endemic area (8% versus 3%, 𝑝 = 0.31). Again, when
healthcare providers responded to these questions, there was
no identifiable trend or statistically significant association.
When comparing physician healthcare providers with
nonphysician healthcare providers, notable differences
occurred between the first and second rounds of survey
administration. More physicians than nonphysicians were
able to correctly identify symptoms of Zika infection in the
first round of surveys (79% versus 65%, resp., 𝑝 = 0.002)
as well as correctly identify symptomatic treatment of Zika
infection (85% versus 52%, 𝑝 = 0.001). These knowledge
gaps closed during the second round of surveys, with
approximately the same amount of both physicians and
nonphysician providers able to identify symptoms (76%
and 80%, 𝑝 = 0.02) and correct treatment (61% and 54%,
𝑝 = 0.007). However, as can be noted from these data,
more physicians were aware of the correct treatment for
the virus in the first round (85%) than in the second round
(61%). Interestingly, in the first round, fewer physicians
than nonphysicians were aware that Zika virus can be
transmitted sexually from a man to a woman (88% versus
96%, 𝑝 = 0.001), which remained true in the second round
(79% versus 86%, 𝑝 = 0.25), although not statistically
significant. Fewer physicians than nonphysicians were
worried for their families due to Zika virus during the
first round of surveys as well (21% versus 43%, 𝑝 = 0.02),
while the opposite was true in the second round (27% of
physicians versus 21% of nonphysician providers, 𝑝 = 0.26).
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Table 3: Responses to “attitude” questions regarding Zika virus disease and infection.
Community Member Responses Healthcare Provider Responses
2016 Survey (%) 2017 Survey (%) 95% CI 2016 Survey (%) 2017 Survey (%) 95% CI
Do you think Zika virus is a serious
problem in your area?
Yes 13/97 (13) 17/166 (10) 8/57 (14) 10/89 (11)
No 67/97 (69) 144/166 (87) 0.0001 48/57 (84) 71/89 (80) 0.18
Do not know 9/97 (9) 0/166 (0) 1/57 (2) 1/89 (1)
No answer 8/97 (8) 5/166 (3) 0/57 (0) 7/89 (7)
Does the Zika virus make you worried for
your family?
Yes 34/97 (35) 48/166 (29) 0.02 17/57 (30) 21/89 (24) 0.18
No 50/97 (52) 109/166 (66) 36/57 (63) 61/89 (69)
Do not know 5/97 (5) 1/166 (1) 2/57 (4) 0/89 (0)
No answer 8/97 (8) 8/166 (5) 2/57 (4) 7/89 (7)
Do you think that a vaccine against Zika
virus is important?
Yes 78/97 (80) 148/166 (89) 0.095 51/57 (89) 77/89 (87) 0.03
No 4/97 (4) 8/166 (5) 3/57 (5) 0/89 (0)
Do not know 7/97 (7) 5/166 (3) 3/57 (5) 5/89 (6)
No answer 8/97 (8) 5/166 (3) 0/57 (0) 7/89 (8)
Should all newly pregnant mothers be
screened for Zika?
Yes 59/97 (61) 101/166 (61) 0.0083 26/57 (46) 47/89 (53) 0.085
No 28/97 (19) 52/166 (31) 27/57 (47) 30/89 (34)
Do not know 12/97 (12) 8/166 (5) 4/57 (7) 5/89 (6)
No answer 8/97 (8) 5/166 (3) 0/57 (0) 7/89 (8)
Are you concerned about Zika virus
spreading through sexual activity?
Yes 65/97 (67) 120/166 (72) 0.18 47/57 (82) 62/89 (70) 0.089
No 17/97 (18) 34/166 (20) 9/57 (16) 15/89 (17)
Do not know 7/97 (7) 7/166 (4) 1/57 (2) 5/89 (6)
No answer 8/97 (8) 5/166 (3) 0/57 (0) 7/89 (8)
Are you concerned about Zika spreading
from mother to unborn baby?
Yes 70/97 (72) 123/166 (74) 53/57 (93) 76/89 (86)
No 9/97 (9) 30/166 (18) 0.018 2/57 (4) 4/89 (4) 0.17
Do not know 8/97 (8) 8/166 (5) 2/57 (4) 2/89 (2)
No answer 10/97 (10) 5/166 (3) 0/57 (0) 7/89 (8)
Are you concerned about having a child
with microcephaly (small head) related to
Zika infection?
Yes 56/97 (58) 98/166 (59) 29/57 (51) 53/89 (60)
No 25/97 (26) 60/166 (36) 0.01 26/57 (46) 29/89 (33) 0.02
Do not know 7/97 (7) 3/166 (2) 2/57 (4) 0/89 (0)
No answer 9/97 (9) 5/166 (3) 0/57 (0) 7/89 (8)
Are you concerned about having a child
with learning disabilities related to Zika
infection?
Yes 54/97 (56) 95/166 (57) 30/57 (53) 51/89 (57)
No 25/97 (26) 61/166 (37) 0.009 23/57 (40) 30/89 (34) 0.04
Do not know 9/97 (9) 4/166 (2) 3/57 (5) 0/89 (0)
No answer 9/97 (9) 6/166 (4) 1/57 (2) 8/89 (9)
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Table 3: Continued.
Community Member Responses Healthcare Provider Responses
2016 Survey (%) 2017 Survey (%) 95% CI 2016 Survey (%) 2017 Survey (%) 95% CI
If you went to an area where Zika is spread
and are a man, are you concerned about
spreading Zika sexually to your partner?
Yes 10/97 (10) 21/166 (13) 13/57 (23) 21/89 (24)
No 7/97 (7) 9/166 (5) 0.37 0/57 (0) 2/89 (2) 0.6
Do not know 3/97 (3) 5/166 (3) 2/57 (4) 2/89 (2)
Not applicable 68/97 (70) 125/166 (75) 40/57 (70) 57/89 (64)
No answer 9/97 (9) 6/166 (4) 2/57 (3) 7/89 (8)
Similarly, fewer physicians than nonphysicians were worried
about having a child with microcephaly related to Zika
infection (41% versus 65%, 𝑝 = 0.0005) or having a child
with disabilities related to Zika infection (41% versus 70%,
𝑝 = 0.001) in the first round. In the second round, however,
these groups responded much more comparably; both
physician and nonphysician providers alike were similarly
worried about having a child with microcephaly (61% versus
59%, 𝑝 = 0.30) or having a child with disabilities related
to Zika infection (55% versus 59%, 𝑝 = 0.44). As a general
trend, the answers to most of the attitude and practice
questions related to Zika virus and protection against it
indicated that physicians were less concerned overall about
the virus compared to nonphysician healthcare providers
in both rounds of surveys, with the difference being less
noticeable in the second round, but the majority of these
were not statistically significant.
4. Discussion
When comparing the community member results from the
2017 round of surveys to those of 2016, it is clear that there
was an improvement over time in baseline knowledge with
regard to Zika virus and infection. These respondents were
more aware of Zika virus existence, virus vector, infectious
symptoms, virus incubation period, and treatment options.
Additionally, community members were more knowledge-
able with regard to commercial vaccine availability, modes
of transmission, mosquito breeding sites and prevention
measures, and status of locally acquired Zika infections.More
of these respondents were also aware of possible pregnancy
and neonatal neurologic comorbidities resulting from a
Zika infection. Weaker knowledge areas during both rounds
of survey administration included the safety of mosquito
prevention medications during pregnancy, including DEET
and permethrin. DEET, the topical insect repellent, has
been endorsed by the US Environmental Protection Agency
to have low acute toxicity without appearing to pose a
significant health concern to humans when used as directed
[10]. Although some limited epidemiologic data suggests that
DEET use in pregnancy may adversely affect learning and
behavior, the evidence for this remains low [11]. Accordingly,
permethrin is largely considered safe in pregnancy. While
there are no randomized-controlled studies that distinguish
outcomes based on human exposure during pregnancy, most
retrospective studies find no adverse perinatal outcomes
after permethrin use [12]. These results reveal that infor-
mation regarding medication safety during pregnancy is
not being translated to the general public appropriately, as
most patients answered incorrectly or “I do not know” to
these questions. Thus, increased counseling for healthcare
providers is required on behalf of their patients. The overall
improvement in knowledge among the community members
that participated in our survey is promising, as this may
parallel the general trend in Zika virus knowledge of general
population as a whole. Since the majority of our survey
respondents prefer to obtain their medical information from
the Internet and healthcare providers (Table 1), this supports
the notion that these resources have served as effective
avenues for disseminating medical knowledge over the past
year.
While there were notable improvements in healthcare
provider knowledge during the survey periods, there were
also areas where knowledge remained stagnant, or even
decreased. More healthcare providers could properly identify
Zika virus symptoms in 2017 compared to 2016, and there
is high baseline knowledge among healthcare providers
regarding mosquito prevention strategies as well as the links
between virus infection and microcephaly. However, while
the percentage of healthcare providers that were aware of
locally acquired Zika infections within the US increased
between survey rounds, this percentage was still less than
90% even in 2017. While the first documented cases of Zika
infection within the US were from June to August 2016
[13] and the end of data collection for the first round of
surveys was August 3, 2016, the second round of surveys
occurred more than six months after the first local Zika virus
infection was reported. Thus, increased healthcare provider
awareness of the status of Zika virus infections within the
US is warranted, as this percentage should ideally near 100%.
Additionally, only about one-half of healthcare providers
were able to report the percentage of infected individuals that
will display symptoms. This gap in provider knowledge may
lead to inadvertent patient harm including improper Zika
screening, as well as inadequate patient counseling. More-
over, our survey discovered alarming areas with declining
healthcare provider knowledge. Specifically, less healthcare
providers were aware of DEET and permethrin safety in
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Table 4: Responses to “practice” questions regarding Zika virus disease and infection.
Community Member Responses Healthcare Provider Responses
2016 Survey (%) 2017 Survey (%) 95% CI 2016 Survey (%) 2017 Survey (%) 95% CI
Do you plan to restrict your travel to a
Zika endemic area?
Yes 48/97 (49) 61/166 (37) 0.048 27/57 (47) 31/89 (35) 0.19
No 34/97 (35) 86/166 (52) 25/57 (44) 47/89 (53)
Do not know 7/97 (7) 12/166 (7) 4/57 (7) 4/89 (5)
No answer 8/97 (8) 7/166 (4) 1/57 (2) 7/89 (8)
If you travel to a Zika endemic area, will
you take protective measures to prevent a
mosquito bite?
Yes 85/97 (88) 147/166 (89) 0.11 53/57 (93) 79/89 (89) 0.09
No 0/97 (0) 7/166 (4) 3/57 (5) 3/89 (3)
Do not know 4/97 (4) 3/166 (2) 1/57 (2) 0/89 (0)
No answer 8/97 (8) 9/166 (5) 0/57 (0) 7/89 (8)
Do you plan on taking protective measures
against mosquito bites while in the US to
prevent Zika infection?
Yes 52/97 (54) 96/166 (58) 0.29 24/57 (42) 36/89 (41) 0.18
No 30/97 (31) 57/166 (34) 31/57 (54) 44/89 (50)
Do not know 7/97 (7) 6/166 (4) 2/57 (4) 2/89 (2)
No answer 8/97 (8) 7/166 (4) 0/57 (0) 7/89 (8)
If you are in an area with mosquitos, you
take the following preventive measures
Use insect repellent 73/97 (75) 138/166 (83) 0.18 47/57 (83) 77/89 (87) 0.018
Remove standing water 62/97 (64) 115/166 (69) 0.56 43/57 (75) 61/69 (69) 0.15
Sleep under a mosquito net 29/97 (30) 60/166 (36) 0.12 11/57 (19) 31/89 (35) 0.003
Use screens on windows and doors 84/97 (87) 145/166 (87) 0.16 50/57 (88) 78/89 (88) 0.01
If you went to an area where Zika virus is
spread and are pregnant, do you plan to
not have sex during the entire pregnancy?
Yes 10/97 (10) 9/166 (5) 0.13 5/57 (9) 7/89 (8) 0.24
No 8/97 (8) 30/166 (18) 10/57 (18) 12/89 (13)
Do not know 19/97 (20) 24/166 (14) 7/57 (12) 12/89 (13)
Not applicable 52/97 (54) 90/166 (54) 34/57 (60) 47/89 (53)
No answer 8/97 (8) 13/166 (8) 1/57 (2) 11/89 (12)
If you went to an area where Zika virus is
spread and are pregnant, do you plan to
use condoms during the entire pregnancy?
Yes 18/97 (19) 29/166 (17) 0.26 13/57 (23) 14/89 (16) 0.2
No 4/97 (4) 18/166 (11) 4/57 (7) 6/89 (7)
Do not know 16/97 (16) 17/166 (10) 4/57 (7) 10/89 (11)
Not applicable 51/97 (53) 89/166 (54) 35/57 (61) 49/89 (55)
No answer 8/97 (8) 13/166 (8) 1/57 (2) 10/89 (11)
If your partner went to an area where Zika
virus is spread and you are pregnant, do
you plan to not have sex during the entire
pregnancy?
Yes 14/97 (14) 13/166 (8) 0.13 7/57 (12) 7/89 (8) 0.067
No 6/97 (6) 25/166 (15) 11/57 (19) 10/89 (11)
Do not know 17/97 (18) 24/166 (14) 4/57 (7) 14/89 (16)
Not applicable 52/97 (54) 89/166 (54) 34/57 (60) 48/89 (54)
No answer 8/97 (8) 15/166 (9) 1/57 (2) 10/89 (11)
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Table 4: Continued.
Community Member Responses Healthcare Provider Responses
2016 Survey (%) 2017 Survey (%) 95% CI 2016 Survey (%) 2017 Survey (%) 95% CI
If your partner went to an area where Zika
virus is spread and you are pregnant, do
you plan to use condoms during the entire
pregnancy?
Yes 19/97 (20) 30/166 (18) 0.31 14/57 (25) 16/89 (18) 0.26
No 3/97 (3) 14/166 (8) 4/57 (7) 5/89 (6)
Do not know 16/97 (16) 17/166 (10) 4/57 (7) 8/89 (9)
Not applicable 51/97 (53) 90/166 (54) 34/57 (60) 50/89 (56)
No answer 8/97 (8) 15/166 (9) 1/57 (2) 10/89 (11)
If you are thinking of becoming pregnant,
do you plan to delay your pregnancy due to
the Zika outbreak?
Yes 11/97 (11) 20/166 (12) 0.78 10/57 (18) 17/89 (19) 0.23
No 12/97 (12) 30/166 (18) 8/57 (14) 9/89 (10)
Do not know 11/97 (11) 16/166 (10) 4/57 (7) 5/89 (6)
Not applicable 53/97 (55) 86/166 (52) 34/57 (60) 47/89 (53)
No answer 10/97 (10) 14/166 (8) 1/57 (2) 11/89 (12)
pregnancy in 2017 when compared to 2016, in parallel to a
greater overall uncertainty with regard to medication safety
as demonstrated by more “I do not know” responses. One
reason for this may be that, as the initial media exposure
about Zika virus subsided, new and novel information about
the virus and its spread was less ubiquitous and therefore
fewer providers were well informed during the 2017 sur-
vey administration. This decline in knowledge may have
detrimental impact on patient counseling about safe virus
prevention practices. Accordingly, there were similar declines
in healthcare provider knowledge regarding options available
for symptomatic treatment of Zika infections, awareness of
a commercially available vaccine, and transmission of Zika
virus vertically (from mother to fetus) and through sexual
intercourse.
The results of the “attitude” questions between both
survey periods reveal a tendency among both community
members and healthcare providers to feel less concerned
about Zika infection than they had previously. According to
our results, there is decreased concern among both groups of
survey respondents regarding concern for family members,
risk of local infection, and transmission to unborn fetuses
as well as postpartum neurologic outcomes for newborns.
Interestingly, while the percentage of healthcare providers
that were aware that Zika virus could be transferred through
sexual intercourse or frommother to fetus decreased between
surveys, there was a parallel decrease in concern for these
outcomes among healthcare providers. The general trend of
the public being less concerned about Zika virus likely derives
from several ideas. First, the WHO lifted the declaration of
Zika as a public health emergency of international concern,
which may have contributed to alleviating fears among the
general public [14]. Also, as more information is learned
and distributed about Zika virus to healthcare professionals
and the community alike, this likely helps to relieve anxiety
and fear among the public. However, there are areas in our
survey that limit our ability to fully extrapolate “attitude”
information. For instance, the question “Are you concerned
about having a child with learning disabilities due to a Zika
infection?” does not clarify the timing of infection in relation
to the pregnancy (i.e., infection before, during, or after
pregnancy). Additionally, there was an upward shift among
community members and healthcare providers alike in terms
of belief in the need for universal Zika infection screening for
pregnant women.However, we did not specify howwe should
screen (i.e., via questionnaire, by symptom or recent travel, or
by serum testing) or when we should screen (prepregnancy
versus trimester-specific screening); thus, respondents may
have interpreted this question differently.
There are interesting trends to be noted when analyzing
the results of the “practice” questions between both survey
periods. The 2017 round of survey responses alludes to an
overall decreased concern among community members with
regard to planned travel to Zika-endemic areas, whether
within theUS or to an international site. However, it is impor-
tant to review these results within the context of the demo-
graphics of the surveyed population. A majority (greater
than 50%) of the survey respondents were not pregnant, nor
were they planning on getting pregnant. Accordingly, there
may have been an increased hesitancy for travel if a greater
percentage of respondents were in a pregnancy-planning
stage of their lives. Additionally, there appears to be a shift
towards increased practice ofmosquito preventionwithin the
United States among community members and healthcare
providers alike. Interestingly, this was not replicated when
asked about mosquito prevention practices if planning to
travel to Zika-endemic areas. As more confirmed cases of
Zika infection occur within the United States, this may
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encourage the general public to begin to practice routine
mosquito prevention practices, rather than only associated
with travel.
There are other limitations of our study that have been
identified. One limitation is that the answers to some of
the questions in the survey may have changed throughout
survey administration. For example, one question asked the
respondent whether any documented cases of Zika virus
transmission in the US have occurred. In the first survey
administration, the answer to this question changed as
initially there were no documented cases, but towards the end
of the survey administration period there had been several
cases noted. This changes the distribution of answers and
the ability to compare this to the second group. Additionally,
when asked about vaccine availability, there may be poten-
tial confusion among healthcare provider respondents with
regard to the current status of an “approved” Zika virus
vaccine. At the time of survey administration, investigational
vaccineswere undergoing clinical trial [15] and this ambiguity
may have contributed to the distribution of answers that
were obtained for this question. Another limitation of our
study is that the total number of respondents in the first
group is significantly less than in the second group, so the
ability to detect statistically significant differences within
this group when comparing the first group to the second
group is diminished. Accordingly, the cohort composition
was different between the two time periods, which would
limit our ability to measure change longitudinally. It is also
unknown exactly howmany potential participants the survey
was sent to via email and how many were approached in
clinic, as the number of participants on each listserv changes
frequently and the number of participants approached in
the clinic was not recorded. This discrepancy in the number
of participants as well as potential differences in baseline
characteristics of responders versus nonresponders to the
survey may contribute an element of participation bias.
However, it can be estimated that the number of potential
participants was about 800 by analyzing current listserv
cohorts and from an estimation of those approached in clinic.
Another limitation is that the sampling of respondents was
convenience sampling, meaning that the survey was dis-
tributed both in the clinic and via the online link based on the
potential participants’ ease of approachability andwillingness
to respond to the survey. It is important to note that our
survey also did not stratify healthcare providers by their
specific profession (i.e., ultrasound technician versus nurse
versus other healthcare professionals) and only asked about
physician versus nonphysician status; this may have played
a role in skewing the survey results, as the second group of
healthcare providers may not represent the same expertise or
experience as the first group of surveyed providers.
5. Conclusion
Zika virus is a new consideration in the field of congenitally
acquired diseases. This study aimed to address the evolving
knowledge, attitudes, and practice regarding Zika virus dur-
ing a tumultuous time of many unknowns for patients and
providers alike. From this study, we can extrapolate that, as
more information is gathered about the virus, more questions
will be answered and there will be fewer fears regarding the
virus. This data can be used to identify gaps in knowledge at
this time about Zika virus and prepare medical providers to
offer counseling regarding safety and preventive practices.
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